Axsome Therapeutics shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $486k | 4.0k | 121.45 |
| 2025-06-30 | $418k | 4.0k | 104.39 |
| 2025-03-31 | $467k | 4.0k | 116.63 |
| 2024-12-31 | $338k | 4.0k | 84.61 |
| 2024-09-30 | $360k | 4.0k | 89.87 |
| 2024-06-30 | $322k | 4.0k | 80.50 |
| 2024-03-31 | $319k | 4.0k | 79.80 |
| 2023-09-30 | $8.8M | 126k | 69.89 |
| 2023-06-30 | $20M | 273k | 71.86 |
| 2019-12-31 | $46M | 442k | 103.36 |
| 2019-09-30 | $8.1M | 400k | 20.24 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management